San Mateo, CA – According to filings with the U.S. Securities and Exchange Commission, Rakuten Medical Inc. is raising $100 Million in a new round of investment. Sources indicate as part of senior management President, Takashi Toraishi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Rakuten Medical Inc.

Rakuten Medical is pioneering the development of new approaches to treat cancer by combining the targeting power of antibodies with laser-activated precision. Rakuten Medical aims to become a leader in precision-targeted therapies through its proprietary photoimmunotherapy platform.

To learn more about Rakuten Medical Inc., visit http://rakuten-med.com/

Contact:
Takashi Toraishi, President
858-925-5619
takashi.toraishi@rakuten-med.com
https://www.linkedin.com/in/takashitoraishi/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved